The center, believed to be the first and largest of its kind, will use psychedelics to study the mind and identify therapies for diseases such as addiction, PTSD, and Alzheimer's. https://hub.jhu.edu/2019/09/04/hopkins-launches-psychedelic-center/
Note from Dr. Milbrandt - I will be training next year to offer these therapies once the FDA opens up expanded access research programs. It probably won't happen until 2021 but exciting none-the-less!